Use of FDA’s Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure
- 8 February 2019
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 42 (7) , 897-906
Abstract
Neurological complications including seizures have been reported with ranolazine. We sought to quantify the risk of seizure-related hospitalizations or emergency department events following ranolazine exposure in the Sentinel System (2006–2015).Keywords
This publication has 19 references indexed in Scilit:
- A Rare Neurological Complication of RanolazineCase Reports in Neurological Medicine, 2013
- Risk of Confirmed Guillain-Barre Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009-2010American Journal of Epidemiology, 2012
- A combined comorbidity score predicted mortality in elderly patients better than existing scoresJournal of Clinical Epidemiology, 2011
- Post-Marketing Safety Evaluation of a Tetanus Toxoid, Reduced Diphtheria Toxoid and 3-Component Acellular Pertussis Vaccine Administered to a Cohort of Adolescents in a United States Health Maintenance OrganizationThe Pediatric Infectious Disease Journal, 2010
- Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currentsJournal of Clinical Investigation, 2010
- Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink ProjectAmerican Journal of Epidemiology, 2009
- Four different study designs to evaluate vaccine safety were equally validated with contrasting limitationsJournal of Clinical Epidemiology, 2006
- Clinical Pharmacokinetics of RanolazineClinical Pharmacokinetics, 2006
- Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJACC, 2004
- A spatial scan statisticCommunications in Statistics - Theory and Methods, 1997